Scalpel and StatLock included with HydroPICC Catheter Kit - PICC-142, Peripherally Inserted Central Catheter

Recall Insight

This FDA Devices action (record #Z-0199-2023) was formally reported on November 16, 2022, with the manufacturer initiating the action on February 24, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Access Vascular, Inc. is listed as the recalling firm, operating out of Billerica, MA. Federal records indicate 79 kits units are affected.

The documented reason for this recall is: Scalpel and StatLock components packaged with specific lots of the HydroPICC catheter have a shorter expiration date than what is listed on the outer kit package. Distribution data in the federal record shows the product reached: Domestic distribution to NC, RI, NJ, and IL. No foreign distribution.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 6 were also issued by FDA Devices. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 4 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.